Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Factor B (C3 proactivator), factor H, factor I]

M Hatanaka1, A Shimizu

  • 1Department of Clinical Pathology, Osaka Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 30, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.

The Biochemical journal·1996
Same author

Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer.

International journal of radiation oncology, biology, physics·1996
Same author

[Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1995
Same author

[A case of testicular tumor associated with the contralateral undescended testis].

Hinyokika kiyo. Acta urologica Japonica·1995
Same author

[Analysis of regulatory mechanism for humoral immunity using transgenic mice of rearranged immunoglobulin genes].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·1995
Same author

Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients.

Internal medicine (Tokyo, Japan)·1995
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles